Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Should You Sell?

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped down before the market opened on Monday . The stock had previously closed at $9.99, but opened at $9.03. Curaleaf shares last traded at $9.70, with a volume of 7,706 shares changing hands.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a research note on Thursday, August 6th. Zacks Research upgraded Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 14th. Three research analysts have rated the stock with a Strong Buy rating and two have given a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Strong Buy”.

Curaleaf Stock Down 1.3%

The firm’s fifty day simple moving average is $7.62 and its 200-day simple moving average is $7.87. The company has a market cap of $2.30 billion, a PE ratio of -75.87 and a beta of 1.56. The company has a quick ratio of 0.73, a current ratio of 1.52 and a debt-to-equity ratio of 1.06.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.25. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.The company had revenue of $340.10 million during the quarter, compared to analysts’ expectations of $332.00 million. As a group, equities research analysts expect that Curaleaf Holdings, Inc. will post 0.01 earnings per share for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.